Advanced Biomed is trading 5.1% down at $7.59 as investors continue to digest last week’s sharp swings following the company’s withdrawal of its planned Form S-1 securities offering and related $25 million stock purchase agreement.
- The stock is currently lagging a broadly positive biotech sector and a wider risk-on market environment.
- Shares face ongoing pressure from profit-taking and investor uncertainty specific to the company's canceled capital-raising plans.